Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

54.44%

64.90%

54.72%

66.15%

Annual Dental Visits (ADV) Total

53.10%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

40.69%

46.74%

43.12%

48.16%

Appropriate Testing for Pharyngitis (CWP)

80.45%

77.56%

88.36%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

85.17%

93.08%

71.11%

91.27%

Asthma Medication Ratio (AMR) Total

68.62%

69.41%

71.11%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

53.55%

66.19%

55.29%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

44.04%

68.61%

68.86 %

71.78%

Breast Cancer Screening (BCS)

46.13%

55.25%

Breast Cancer Screening (BCS-E)

46.00%

54.94%

47.88%

56.66%

Cervical Cancer Screening (CCS)

50.50%

59.85%

51.34%

60.10%

Childhood Immunization Status (CIS) Combination #10

32.36%

35.04%

29.07%

31.32%

Chlamydia Screening in Women (CHL) Total

60.11%

61.07%

60.69%

61.46%

Controlling High Blood Pressure (CBP)

47.45%

65.45%

58.88%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

84.06%

80.86%

85.49%

83.51%

Eye Exam for Patients With Diabetes (EED)

43.31%

56.20%

48.42%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

27.27%

27.73%

26.13%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

30.15%

46.35%

33.31%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

33.02%

41.03%

38.46%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

43.51%

37.31%

44.96%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

57.64%

57.90%

60.00%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

60.00%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

42.34%

55.72%

51.34%

59.64%

Immunizations for Adolescents (IMA) Combination #2

30.90%

38.93%

32.00%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

49.85%

16.94%

47.90%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

26.55%

38.80%

27.79%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

34.49%

39.01%

31.71%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

31.71%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

18.13%

31.93%

22.82%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

73.89%

75.79%

74.04%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

82.14%

86.96%

80.79%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

96.41%

≤ 92.72%

100.71%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

80.29%

86.86%

81.75%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

73.48%

80.78%

80.54%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

24.84%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

24.84%

25.81%

22.52%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

3.10%

≤ 2.45%

4.85%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

79.57%

81.64%

79.90%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

65.72%

73.63%

67.82%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

65.15%

67.07%

65.93%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

64.09%

70.37%

65.38%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

66.47%

63.89%

71.39%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

63.38%

75.44%

59.41%

72.74%

Use of Opioids at High Dosage (HDO)

0.74%

≤ 2.19%

0.60%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.00%

≤ 0.87%

0.00%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

74.70%

83.21%

76.89%

86.20%